Optimizing surgical margins in breast conservation

International Journal of Surgical Oncology

Volumn 2012, Issue , 2012, Pages

  Ananthakrishnan, Preya ^a   Balci, Fatih Levent ^a   Crowe, Joseph P ^b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872163514     PISSN: 20901402     EISSN: 20901410     Source Type: Journal    
DOI: 10.1155/2012/585670     Document Type: Review

References (76)

1. Fisher B., Anderson S., Bryant J., Margolese R. G., Deutsch M., Fisher E. R., Jeong J. H., Wolmark N., Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine 2002 347 16 1233 1241 2-s2.0-0037126341 10.1056/NEJMoa022152 (Pubitemid 35176242)
2. Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., Aguilar M., Marubini E., Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New England Journal of Medicine 2002 347 16 1227 1232 2-s2.0-0037126350 10.1056/NEJMoa020989 (Pubitemid 35176241)
3. Lovrics P. J., Cornacchi S. D., Farrokhyar F., Garnett A., Chen V., Franic S., Simunovic M., The relationship between surgical factors and margin status after breast-conservation surgery for early stage breast cancer. American Journal of Surgery 2009 197 6 740 746 2-s2.0-66449129614 10.1016/j.amjsurg. 2008.03.007
4. Acosta J. A., Greenlee J. A., Dean Gubler K., Goepfert C. J., Ragland J. J., Surgical margins after needle-localization breast biopsy. American Journal of Surgery 1995 170 6 643 646 2-s2.0-0028841454 10.1016/S0002-9610(99)80033-6
5. Gajdos C., Ian Tartter P., Bleiweiss I. J., Hermann G., De Csepel J., Estabrook A., Rademaker A. W., Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Annals of Surgery 2002 235 2 246 251 2-s2.0-0036158292 10.1097/00000658-200202000-00013 (Pubitemid 34111954)
6. Papa M. Z., Klein E., Davidson B., Karni T., Sperber F., Koller M., Ravid M., Ari G. B., The effect of anesthesia type on needle localization breast biopsy: another point of view. American Journal of Surgery 1996 171 2 242 243 2-s2.0-0030025134 10.1016/S0002-9610(97)89558-X (Pubitemid 26060172)
7. Mullen R., Macaskill E. J., Khalil A., Involved anterior margins after breast conserving surgery: is re-excision required? European Journal of Surgical Oncology 2012 38 4 302 306
8. Goldhirsch A., Ingle J. N., Gelber R. D., Coates A. S., Thürlimann B., Senn H. J., Thresholds for therapies: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2009. Annals of Oncology 2009 20 8 1319 1329 2-s2.0-69449090120 10.1093/annonc/mdp322
9. Blair S. L., Thompson K., Rococco J., Malcarne V., Beitsch P. D., Ollila D. W., Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? Journal of the American College of Surgeons 2009 209 5 608 613 2-s2.0-70350130594 10.1016/j.jamcollsurg.2009.07.026
10. Wang S. Y., Chu H., Shamliyan T., Network meta-analysis of margin threshold for women with ductal carcinoma in situ. Journal of the National Cancer Institute 2012 104 7 507 516
11. Houssami N., MacAskill P., Marinovich M. L., Dixon J. M., Irwig L., Brennan M. E., Solin L. J., Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. European Journal of Cancer 2010 46 18 3219 3232 2-s2.0-78649632377 10.1016/j.ejca.2010.07.043
12. Holland R., Veling S. H. J., Mravunac M., Hendriks J. H. C. L., Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer 1985 56 5 979 990 2-s2.0-0021883671 (Pubitemid 15003474)
13. Morrow M., Harris J. R., Schnitt S. J., Surgical margins in lumpectomy for breast cancer-bigger is not better. New England Journal of Medicine 2012 367 1 79 82
14. Margenthaler J. A., Gao F., Klimberg V. S., Margin index: a new method for prediction of residual disease after breast-conserving surgery. Annals of Surgical Oncology 2010 17 10 2696 2701 2-s2.0-78049475247 10.1245/s10434-010- 1079-z
15. Clough K. B., Lewis J. S., Couturaud B., Fitoussi A., Nos C., Falcou M. C., Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Annals of Surgery 2003 237 1 26 34 2-s2.0-0037208686 10.1097/00000658-200301000-00005 (Pubitemid 36622314)
16. Kaur N., Petit J. Y., Rietjens M., Maffini F., Luini A., Gatti G., Rey P. C., Urban C., De Lorenzi F., Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer. Annals of Surgical Oncology 2005 12 7 539 545 2-s2.0-21244500229 10.1245/ASO.2005.12.046 (Pubitemid 40898036)
17. Rietjens M., Urban C. A., Rey P. C., Mazzarol G., Maisonneuve P., Garusi C., Intra M., Yamaguchi S., Kaur N., De Lorenzi F., Matthes A. G. Z., Zurrida S., Petit J. Y., Long-term oncological results of breast conservative treatment with oncoplastic surgery. Breast 2007 16 4 387 395 2-s2.0-34547191618 10.1016/j.breast.2007.01.008 (Pubitemid 47109197)
18. Giacalone P. L., Roger P., Dubon O., El Gareh N., Daurés J. P., Laffargue F., Lumpectomy versus oncoplastic surgery for breast-conserving therapy of cancer. A prospective study about 99 patients. Annales de Chirurgie 2006 131 4 256 261 2-s2.0-33646087905 10.1016/j.anchir.2005.12.011
19. Meretoja T. J., Svarvar C., Jahkola T. A., Outcome of oncoplastic breast surgery in 90 prospective patients. American Journal of Surgery 2010 200 2 224 228 2-s2.0-77955906975 10.1016/j.amjsurg.2009.09.026
20. Fitoussi A. D., Berry M. G., Famà F., Falcou M. C., Curnier A., Couturaud B., Reyal F., Salmon R. J., Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases. Plastic and Reconstructive Surgery 2010 125 2 454 462 2-s2.0-76949085585 10.1097/PRS.0b013e3181c82d3e
21. Chakravorty A., Shrestha A. K., Sanmugalingam N., How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery. European Journal of Surgical Oncology 2012 38 5 395 398
22. Fisher S. C., Klimberg S. V., Seema K., Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS. Annals of Surgical Oncology 2011 18 3155 3159
23. Anderson S. J., Wapnir I., Dignam J. J., Fisher B., Mamounas E. P., Jeong J. H., Geyer C. E., Wickerham D. L., Costantino J. P., Wolmark N., Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. Journal of Clinical Oncology 2009 27 15 2466 2473 2-s2.0-66349105317 10.1200/JCO.2008.19. 8424
24. Reedijk M., Hodgson N., Gohla G., A prospective study of tumor and technical factors associated with positive margins in breast-conservation therapy for non-palpable malignancy. American Journal of Surgery 2012 263 268
25. Cabioglu N., Hunt K. K., Sahin A. A., Kuerer H. M., Babiera G. V., Singletary S. E., Whitman G. J., Ross M. I., Ames F. C., Feig B. W., Buchholz T. A., Meric-Bernstam F., Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Annals of Surgical Oncology 2007 14 4 1458 1471 2-s2.0-34047214302 10.1245/s10434-006-9236-0 (Pubitemid 46536814)
26. Fisher B., Dignam J., Bryant J., DeCillis A., Wickerham D. L., Wolmark N., Costantino J., Redmond C., Fisher E. R., Bowman D. M., Deschênes L., Dimitrov N. V., Margolese R. G., Robidoux A., Shibata H., Terz J., Paterson A. H. G., Feldman M. I., Farrar W., Evans J., Lickley H. L., Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. Journal of the National Cancer Institute 1996 88 21 1529 1542 2-s2.0-10344238569 10.1093/jnci/88.21.1529 (Pubitemid 26374506)
27. Fisher B., Dignam J., Mamounas E. P., Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. Journal of Clinical Oncology 1996 14 1982 1992
28. Romond E. H., Perez E. A., Bryant J., Suman V. J., Geyer C. E., Davidson N. E., Tan-Chiu E., Martino S., Paik S., Kaufman P. A., Swain S. M., Pisansky T. M., Fehrenbacher L., Kutteh L. A., Vogel V. G., Visscher D. W., Yothers G., Jenkins R. B., Brown A. M., Dakhil S. R., Mamounas E. P., Lingle W. L., Klein P. M., Ingle J. N., Wolmark N., Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. New England Journal of Medicine 2005 353 16 1673 1684 2-s2.0-26844536978 10.1056/NEJMoa052122 (Pubitemid 41464706)
29. Kyndi M., Sørensen F. B., Knudsen H., Overgaard M., Nielsen H. M., Overgaard J., Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer. Journal of Clinical Oncology 2008 26 9 1419 1426 2-s2.0-41149125468 10.1200/JCO.2007.14.5565
30. Millar E. K. A., Graham P. H., O'Toole S. A., McNeil C. M., Browne L., Morey A. L., Eggleton S., Beretov J., Theocharous C., Capp A., Nasser E., Kearsley J. H., Delaney G., Papadatos G., Fox C., Sutherland R. L., Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. Journal of Clinical Oncology 2009 27 28 4701 4708 2-s2.0-70350441646 10.1200/JCO.2008.21.7075
31. Nguyen P. L., Taghian A. G., Katz M. S., Niemierko A., Abi Raad R. F., Boon W. L., Bellon J. R., Wong J. S., Smith B. L., Harris J. R., Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. Journal of Clinical Oncology 2008 26 14 2373 2378 2-s2.0-44249114098 10.1200/JCO.2007.14.4287
32. Abdulkarim B. S., Cuartero J., Hanson J., Deschênes J., Lesniak D., Sabri S., Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. Journal of Clinical Oncology 2011 29 21 2852 2858 2-s2.0-79960714832 10.1200/JCO.2010.33. 4714
33. Ho A. Y., Gupta G., King T. A., Favorable prognosis in patients with T1a/bN0 triple-negative breast cancers treated with multimodality therapy. Cancer 2012 118 20 4944 4952
34. Mamounas E. P., Tang G., Fisher B., Paik S., Shak S., Costantino J. P., Watson D., Geyer C. E., Wickerham D. L., Wolmark N., Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. Journal of Clinical Oncology 2010 28 10 1677 1683 2-s2.0-77950482645 10.1200/JCO.2009.23.7610
35. Paik S., Tang G., Shak S., Kim C., Baker J., Kim W., Cronin M., Baehner F. L., Watson D., Bryant J., Costantino J. P., Geyer C. E., Wickerham D. L., Wolmark N., Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. Journal of Clinical Oncology 2006 24 23 3726 3734 2-s2.0-33744814477 10.1200/JCO.2005.04.7985 (Pubitemid 46622311)
36. Yi M., Buchholz T. A., Meric-Bernstam F., Bedrosian I., Hwang R. F., Ross M. I., Kuerer H. M., Luo S., Gonzalez-Angulo A. M., Buzdar A. U., Symmans W. F., Feig B. W., Lucci A., Huang E. H., Hunt K. K., Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Annals of Surgery 2011 253 3 572 579 2-s2.0-79951675741 10.1097/SLA.0b013e318208fc2a
37. Houssami N., Ciatto S., Macaskill P., Lord S. J., Warren R. M., Dixon J. M., Irwig L., Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. Journal of Clinical Oncology 2008 26 19 3248 3258 2-s2.0-49249112188 10.1200/JCO.2007.15.2108
38. Crowe J. P., Patrick R. J., Rim A., The importance of preoperative breast MRI for patients newly diagnosed with breast cancer. Breast Journalournal 2009 15 1 52 60 2-s2.0-58149287964 10.1111/j.1524-4741.2008.00671.x
39. Bleicher R. J., Ciocca R. M., Egleston B. L., Sesa L., Evers K., Sigurdson E. R., Morrow M., Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. Journal of the American College of Surgeons 2009 209 2 180 187 2-s2.0-67650717267 10.1016/j.jamcollsurg.2009.04.010
40. Shin H. C., Han W., Moon H. G., Limited value and utility of breast MRI in patients undergoing breast-conserving cancer surgery. Annals of Surgical Oncology 2012 19 8 2572 2579
41. Kropcho L. C., Steen S. T., Chung A. P., Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ. Breast Journal 2012 18 2 151 156
42. Sweeting R. S., Klauber-Demore N., Meyers M. O., Young women with locally advanced breast cancer who achieve breast conservation after neoadjuvant chemotherapy have a low local recurrence rate. American Surgeon 2011 77 7 850 855
43. Huang E. H., Strom E. A., Perkins G. H., Oh J. L., Chen A. M., Meric-Bernstam F., Hunt K. K., Sahin A. A., Hortobagyi G. N., Buchholz T. A., Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. International Journal of Radiation Oncology Biology Physics 2006 66 2 352 357 2-s2.0-33748319470 10.1016/j.ijrobp.2006.04.046 (Pubitemid 44332738)
44. Falou O., Soliman H., Sadeghi-Naini A., Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy. Translational Oncology 2012 5 4 238 246
45. Liberman L., Kaplan J., Van Zee K. J., Morris E. A., LaTrenta L. R., Abramson A. E., Dershaw D. D., Bracketing wires for preoperative breast needle localization. American Journal of Roentgenology 2001 177 3 565 572 2-s2.0-0034864315 (Pubitemid 32802339)
46. Bathla L., Harris A., Davey M., High resolution intra-operative two-dimensional specimen mammography and its impact on second operation for re-excision of positive margins at final pathology after breast conservation surgery. American Journal of Surgery 2011 202 4 387 394
47. Rahusen F. D., Bremers A. J. A., Fabry H. F. J., Taets van Amerongen A. H. M., Boom R. P. A., Meijer S., Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Annals of Surgical Oncology 2002 9 10 994 998 2-s2.0-0036895980 10.1245/ASO.2002.04.009 (Pubitemid 35424634)
48. Klein R. L., Mook J. A., Euhus D. M., Evaluation of a hydrogel based breast biopsy marker (HydroMARK) as an alternative to wire and radioactive seed localization for non-palpable breast lesions. Journal of Surgical Oncology 2012 105 6 591 594
49. Tafra L., Fine R., Whitworth P., Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Annals of Surgical Oncology 2002 9 10 994 998
50. Sajid M. S., Parampalli U., Haider Z., Comparison of radioguided occult lesion localization (ROLL) and wire localization for non-palpable breast cancers: a meta-analysis. Journal of Surgical Oncology 2012 105 8 852 858
51. Krekel N. M. A., Zonderhuis B. M., Stockmann H. B. A. C., Schreurs W. H., Van Der Veen H., De Lange De Klerk E. S. M., Meijer S., Van Den Tol M. P., A comparison of three methods for nonpalpable breast cancer excision. European Journal of Surgical Oncology 2011 37 2 109 115 2-s2.0-79251594108 10.1016/j.ejso.2010.12.006
52. Cendan J. C., Coco D., Copeland E. M. III, Accuracy of intra-operative touch prep frozen-section analysis of breast cancer lumpectomy bed margins. Journal of the American College of Surgeons 2005 201 194 198 (Pubitemid 40994951)
53. D'Halluin F., Tas P., Rouquette S., Bendavid C., Foucher F., Meshba H., Blanchot J., Coué O., Levêque J., Intra-operative touch preparation cytology following lumpectomy for breast cancer: a series of 400 procedures. Breast 2009 18 4 248 253 2-s2.0-69749111472 10.1016/j.breast.2009.05.002
54. Valdes E. K., Boolbol S. K., Cohen J. M., Feldman S. M., Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy? Annals of Surgical Oncology 2007 14 3 1045 1050 2-s2.0-33847368964 10.1245/s10434-006-9263-x (Pubitemid 46348828)
55. Allweis T. M., Kaufman Z., Lelcuk S., Pappo I., Karni T., Schneebaum S., Spector R., Schindel A., Hershko D., Zilberman M., Sayfan J., Berlin Y., Hadary A., Olsha O., Paran H., Gutman M., Carmon M., A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery. American Journal of Surgery 2008 196 4 483 489 2-s2.0-52249085654 10.1016/j.amjsurg.2008.06.024
56. Doyle T. E., Factor R. E., Ellefson C. L., High-frequency ultrasound for intraoperative margin assessments in breast conservation surgery: a feasibility study. BMC Cancer 2011 11, article 444
57. Dooley W., Bong J., Parker J., Redefining lumpectomy using a modification of the "sick lobe" hypothesis and ductal anatomy. International Journal of Breast Cancer 2011 2011 7263 7284
58. Manenti G., Perretta T., Gaspari E., Pistolese C. A., Scarano L., Cossu E., Bonanno E., Buonomo O. C., Petrella G., Simonetti G., Masala S., Percutaneous local ablation of unifocal subclinical breast cancer: clinical experience and preliminary results of cryotherapy. European Radiology 2011 21 11 2344 2353 2-s2.0-79959208095 10.1007/s00330-011-2179-2
59. Dowlatshahi K., Francescatti D. S., Bloom K. J., Laser therapy for small breast cancers. American Journal of Surgery 2002 184 4 359 363 2-s2.0-0036803427 10.1016/S0002-9610(02)00942-X (Pubitemid 35287361)
60. Klimberg V. S., Kepple J., Shafirstein G., Adkins L., Henry-Tillman R., Youssef E., Brito J., Talley L., Korourian S., eRFA: excision followed by RFA-a new technique to improve local control in breast cancer. Annals of Surgical Oncology 2006 13 11 1422 1433 2-s2.0-33751017406 10.1245/s10434-006-9151-4 (Pubitemid 44749653)
61. Vaidya J. S., Joseph D. J., Tobias J. S., Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, noninferiority phase 3 trial. The Lancet 2010 376 9735 91 102 2-s2.0-77954981069
62. Graham R. A., Homer M. J., Katz J., Rothschild J., Safaii H., Supran S., The pancake phenomenon contributes to the inaccuracy of margin assessment in patients with breast cancer. American Journal of Surgery 2002 184 2 89 93 2-s2.0-0036348717 10.1016/S0002-9610(02)00902-9 (Pubitemid 34880211)
63. Huston T. L., Pigalarga R., Osborne M. P., Tousimis E., The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery. American Journal of Surgery 2006 192 4 509 512 2-s2.0-33748417556 10.1016/j.amjsurg.2006.06.021 (Pubitemid 44344190)
64. Rizzo M., Iyengar R., Gabram S. G. A., Park J., Birdsong G., Chandler K. L., Mosunjac M. B., The effects of additional tumor cavity sampling at the time of breast-conserving surgery on final margin status, volume of resection, and pathologist workload. Annals of Surgical Oncology 2010 17 1 228 234 2-s2.0-74649084597 10.1245/s10434-009-0643-x
65. Molina M. A., Snell S., Franceschi D., Breast specimen orientation. Annals of Surgical Oncology 2009 16 2 285 288
66. Dooley W. C., Parker J., Understanding the mechanisms creating false positive lumpectomy margins. American Journal of Surgery 2005 190 4 606 608 2-s2.0-24944468657 10.1016/j.amjsurg.2005.06.023 (Pubitemid 41306087)
67. Feldman S. M., Valdes E. K., Boolbol S. K., Cohen J. M., Gross J., Excisional breast specimen orientation/processing: a multidisciplinary approach for breast conservation. Seminars in Breast Disease 2006 8 3 121 126 2-s2.0-33749535748 10.1053/j.sembd.2006.07.003
68. Singh M., Singh G., Hogan K. T., Atkins K. A., Schroen A. T., The effect of intraoperative specimen inking on lumpectomy re-excision rates. World Journal of Surgical Oncology 2010 8, article 4 2-s2.0-76749092632 10.1186/1477-7819-8-4
69. Gibson G. R., Lesnikoski B. A., Yoo J., Mott L. A., Cady B., Barth R. J., A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins. Annals of Surgical Oncology 2001 8 9 693 704 2-s2.0-0034790174 10.1245/aso.2001.8.9.693 (Pubitemid 32952483)
70. Holmes D. R., Schooler W., Smith R., Oncoplastic approaches to breast conservation. International Journal of Breast Cancer 2011 2011 303 379
71. Newman L. A., Kuerer H. M., McNeese M. D., Hunt K. K., Gurtner G. C., Vlastos G. S., Robb G., Singletary S. E., Reduction mammoplasty improves breast conservation therapy in patients with macromastia. American Journal of Surgery 2001 181 3 215 220 2-s2.0-0035270098 10.1016/S0002-9610(01)00563-3 (Pubitemid 32480218)
72. Yang J. D., Lee J. W., Cho Y. K., Surgical techniques for personalized oncoplastic surgery in breast cancer patients with small- to moderate-sized breasts (part 2): volume replacement. Journal of Breast Cancer 2012 15 1 7 14
73. Giacalone P. L., Roger P., Dubon O., Gareh N. E., Rihaoui S., Taourel P., Daurés J. P., Comparative study of the accuracy of breast resection in oncoplastic surgery and quadrantectomy in breast cancer. Annals of Surgical Oncology 2007 14 2 605 614 2-s2.0-33846604631 10.1245/s10434-006-9098-5 (Pubitemid 46175306)
74. Asgeirsson K. S., Rasheed T., McCulley S. J., Macmillan R. D., Oncological and cosmetic outcomes of oncoplastic breast conserving surgery. European Journal of Surgical Oncology 2005 31 8 817 823 2-s2.0-26444500070 10.1016/j.ejso.2005.05.010 (Pubitemid 41435249)
75. Iwuchukwu O. C., Harvey J. R., Dordea M., Critchley A. C., Drew P. J., The role of oncoplastic therapeutic mammoplasty in breast cancer surgery-a review. Surgical Oncology 2012 21 2 133 141 2-s2.0-79952468420 10.1016/j.suronc.2011.01.002
76. Roberts J. M., Clark C. J., Campbell M. J., Paige K. T., Incidence of abnormal mammograms after reduction mammoplasty: implications for oncoplastic closure. American Journal of Surgery 2011 201 5 608 610 2-s2.0-79955681361 10.1016/j.amjsurg.2011.01.019